# Production of a Dulaglutide Analogue by Apoptosis-Resistant Chinese Hamster Ovary Cells in a 3-Week Fed-Batch Process.

> PubMed lists PMID 41471386 in Pharmaceuticals (Basel, Switzerland) as Journal Article, with publication-date metadata of 2025-12-16 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-41471386-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-03
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41471386-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41471386-dulaglutide-v1.json
- Content SHA-256: `1b0d823c5b98c95022b875a1d9a2e01e77e8c3062127aa296c3ecf24b7abbc1b`

## Claims and source pins

### Headline

Production of a Dulaglutide Analogue by Apoptosis-Resistant Chinese Hamster Ovary Cells in a 3-Week Fed-Batch Process. ([`pubmed-observation-pmid-41471386-2026-01-03-d175739d946b`](#source-pubmed-observation-pmid-41471386-2026-01-03-d175739d946b))

### Summary

PubMed lists PMID 41471386 in Pharmaceuticals (Basel, Switzerland) as Journal Article, with publication-date metadata of 2025-12-16 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41471386-2026-01-03-d175739d946b`](#source-pubmed-observation-pmid-41471386-2026-01-03-d175739d946b))

### Paragraph 1

PubMed lists PMID 41471386 in Pharmaceuticals (Basel, Switzerland) as Journal Article, with publication-date metadata of 2025-12-16 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41471386-2026-01-03-d175739d946b`](#source-pubmed-observation-pmid-41471386-2026-01-03-d175739d946b))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41471386-2026-01-03-d175739d946b`](#source-pubmed-observation-pmid-41471386-2026-01-03-d175739d946b))

## Sources

<a id="source-pubmed-observation-pmid-41471386-2026-01-03-d175739d946b"></a>
- **Production of a Dulaglutide Analogue by Apoptosis-Resistant Chinese Hamster Ovary Cells in a 3-Week Fed-Batch Process. · retained source version 1:2026-01-03:current:d175739d946bf90c08709844e4b3ab7f1a878cc7eaec47d229f6c041bc8af371** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41471386/) (`pubmed-observation-pmid-41471386-2026-01-03-d175739d946b`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Production of a Dulaglutide Analogue by Apoptosis-Resistant Chinese Hamster Ovary Cells in a 3-Week Fed-Batch Process." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41471386-dulaglutide-v1.json SHA-256: 1b0d823c5b98c95022b875a1d9a2e01e77e8c3062127aa296c3ecf24b7abbc1b.